Diamyd Medical AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 11.16B |
---|---|---|---|---|---|
Net income 2018 | 25M 272M | Net income 2019 | 77M 837M | EV / Sales 2018 | - |
Net cash position 2018 | 253M 2.75B | Net cash position 2019 | 83.08M 903M | EV / Sales 2019 | - |
P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.36% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |